CUBN and neoplasm: Taken together, these findings establish that CUBN is downregulated in aggressive ocular tumor types but retained or upregulated in less aggressive or mixoid forms, suggesting a role as a marker of differentiation state and a potential mediator of tumor metabolism in ocular oncology.